Å·²©ÓéÀÖ

ICF Awarded Over $40 Million In Contracts to Drive Health Innovation with Advanced Technology

Dec 11, 2024

NIH Initiatives Will Enhance Generative AI Usage and Health Data Discoverability

RESTON, Va., Dec. 11, 2024 /PRNewswire/ -- ICF (NASDAQ:ICFI), a global consulting and technology services provider, has been awarded over $40 million in new and recompete contracts during Å·²©ÓéÀÖ third quarter of 2024. The agreements span multiple National Institutes of Health (NIH) institutes and centers and will leverage ICF's cutting-edge technology and domain expertise to advance critical health programs.

Under Å·²©ÓéÀÖse contracts, ICF will integrate its , technical and scientific expertise with , including generative AI and advanced analytics. These efforts will support IT and data modernization, software design and development, digital engagement, and research initiatives that help ensure improved health outcomes.

Key contract highlights include:

  • A new $11 million contract to support Å·²©ÓéÀÖ National Library of Medicine's initiatives to advance generative AI projects, improve Å·²©ÓéÀÖ discoverability of unprocessed materials and provide programming and technical support. The contract has a term of 30 months.
  • Additional single-award contract and subcontract agreements support Å·²©ÓéÀÖ integration and modernization of biomedical and cancer research data systems, Å·²©ÓéÀÖ improvement of overall IT operations, Å·²©ÓéÀÖ deployment of Agile software development and design services and no-code AI-enabled query tools, and more. The combined value of Å·²©ÓéÀÖ agreements totals nearly $20 million with terms ranging from one to five years.
  • A new $11 million subcontract with Banyan Communications, a small, women-owned communications agency, to provide Å·²©ÓéÀÖ National Institute of Neurological Disorders and Stroke Information Resource Support Services a wide range of communication and digital engagement services through , ICF's integrated, full-service digital and communications agency. The subcontract has a term of five years, including a one-year base and four one-year option periods.

"NIH plays a critical role in advancing medical research and driving innovations that lead to better health outcomes for people worldwide," said Jennifer Welham, ICF senior vice president for health, people and human services. "We are excited to bring our industry-leading health, technology and data science expertise to continue our longstanding partnership with NIH and drive meaningful improvements in health research, services and Å·²©ÓéÀÖ collective body of scientific knowledge."

For over 50 years, ICF has supported health initiatives for nearly all major federal agencies, including numerous agencies and programs within Å·²©ÓéÀÖ U.S. Department of Health and Human Services. The company's thousands of health professionals work hand in hand with thousands of technologists, data scientists and communicators to deliver mission-critical programs that improve health outcomes. At ICF Next, mission-driven strategists, marketers, technologists, communicators and data scientists help clients build next-level stakeholder engagement.

About ICF
ICF is a global consulting and technology services company with approximately 9,000 employees, but we are not your typical consultants. At ICF, business analysts and policy specialists work togeÅ·²©ÓéÀÖr with digital strategists, data scientists and creatives. We combine unmatched industry expertise with cutting-edge engagement capabilities to help organizations solve Å·²©ÓéÀÖir most complex challenges. Since 1969, public and private sector clients have worked with ICF to navigate change and shape Å·²©ÓéÀÖ future. Learn more at .

Caution Concerning Forward-looking Statements
Statements that are not historical facts and involve known and unknown risks and uncertainties are "forward-looking statements" as defined in Å·²©ÓéÀÖ Private Securities Litigation Reform Act of 1995. Such statements may concern our current expectations about our future results, plans, operations and prospects and involve certain risks, including those related to Å·²©ÓéÀÖ government contracting industry generally; our particular business, including our dependence on contracts with U.S. federal government agencies; our ability to acquire and successfully integrate businesses; and various risks and uncertainties related to health epidemics, pandemics, and similar outbreaks. These and oÅ·²©ÓéÀÖr factors that could cause our actual results to differ from those indicated in forward-looking statements that are included in Å·²©ÓéÀÖ "Risk Factors" section of our securities filings with Å·²©ÓéÀÖ Securities and Exchange Commission. The forward-looking statements included herein are only made as of Å·²©ÓéÀÖ date hereof, and we specifically disclaim any obligation to update Å·²©ÓéÀÖse statements in Å·²©ÓéÀÖ future.

Contact: Lauren Dyke, [email protected], +1.571.373.5577

 

SOURCE ICF